| Autor: |
Jain M; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: jainm@mskcc.org., Autuori I; Epidemiology & Biostatistics Department, Memorial Sloan Kettering Cancer Center, New York, New York., Everett N; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Harris U; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Yamada M; Future Industries Institute, University of South Australia, Australia., Prow T; Future Industries Institute, University of South Australia, Australia; York Biomedical Research Institute, Hull York Medical School, University of York, United Kingdom., Busam K; Pathology Department, Memorial Sloan Kettering Cancer Center, New York, New York., Marchetti MA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Halpern AC; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Orlow I; Epidemiology & Biostatistics Department, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Abstrakt: |
Competing Interests: Conflicts of interest Drs Yamada and Prow have a conflict of interest with Trajan Scientific & Medical Pty Ltd as they are currently commercializing microbiopsy. Drs Jain, Busam, Marchetti, and Halpern and authors Autuori, Everett, Harris, and Orlow do not have any conflicts of interest to disclose. |
Full Text from ScienceDirect